Hepatocellular carcinoma Clinical Trials Database - Free Access to 402 Studies
Access comprehensive clinical trial information for Hepatocellular carcinoma through Pure Global AI's free database. This collection includes 402 clinical trials across multiple phases including N/A, Phase 2, Phase 4. Currently, 134 trials are actively recruiting participants.
Research for Hepatocellular carcinoma is being conducted in Japan, China, South Korea and 7+ other countries. Leading sponsors include West China Hospital, Sichuan University and University of Tsukuba. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Angiogenesis and tumour proliferation in hepatocellular carcinoma after trans-arterial therapy
A Randomized, Controlled Phase 3 Study of Cabozantinib (XL184)
Multi-center retrospective study on efficacy and safety of new-generation microwave ablation in patients with hepatocellular carcinoma
Comparison between stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Meta-analysis and systematic review.
Prospective Evaluation of the Use of PET-CT in Hepatocarcinoma
Comparison of Lenvatinib with radiofrequency ablation and radiofrequency ablation alone with radiofrequency ablation planned hepatocellular carcinoma : randomized, prospective, multicenter trial
Exploration of Biomarkers for AFP-PIVKA-II Double-Negative Cases in Hepatocellular Carcinoma
Untitled Trial
Untitled Trial
Untitled Trial
Effects of alkalization therapy for hepatocellular carcinoma: a retrospective study
Untitled Trial
Questionnaire survey of patients and physicians for Early-stage hepatocellular carcinoma
Untitled Trial
Untitled Trial
Prospective feasibility study of ultrasonography-combined follow-up approach for post-radiotherapy hepatocellular carcinoma
Untitled Trial
Japanese Society of Hepato-Biliary-Pancreatic Surgery, Project 09 of Hepatic Surgery National survey of surgical treatment for hepatocellular carcinoma associated with inferior vena cava invasion
Prospective Observational Study of Systemic Therapy for HCC in Japan: Exploratory Biomarker-Analysis
Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma
Pure Global AI provides free access to 402 clinical trials studying Hepatocellular carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include West China Hospital, Sichuan University, University of Tsukuba, Niigata Hepatocellular Carcinoma Therapy Study Group, among others.